JP2002543179A5 - - Google Patents

Download PDF

Info

Publication number
JP2002543179A5
JP2002543179A5 JP2000615381A JP2000615381A JP2002543179A5 JP 2002543179 A5 JP2002543179 A5 JP 2002543179A5 JP 2000615381 A JP2000615381 A JP 2000615381A JP 2000615381 A JP2000615381 A JP 2000615381A JP 2002543179 A5 JP2002543179 A5 JP 2002543179A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000615381A
Other versions
JP4270759B2 (ja
JP2002543179A (ja
Filing date
Publication date
Priority claimed from SE9901572A external-priority patent/SE9901572D0/xx
Application filed filed Critical
Publication of JP2002543179A publication Critical patent/JP2002543179A/ja
Publication of JP2002543179A5 publication Critical patent/JP2002543179A5/ja
Application granted granted Critical
Publication of JP4270759B2 publication Critical patent/JP4270759B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000615381A 1999-05-03 2000-05-03 新規化合物 Expired - Fee Related JP4270759B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9901572-9 1999-05-03
SE9901572A SE9901572D0 (sv) 1999-05-03 1999-05-03 New compounds
PCT/SE2000/000846 WO2000066550A1 (en) 1999-05-03 2000-05-03 New compounds

Publications (3)

Publication Number Publication Date
JP2002543179A JP2002543179A (ja) 2002-12-17
JP2002543179A5 true JP2002543179A5 (ja) 2005-12-22
JP4270759B2 JP4270759B2 (ja) 2009-06-03

Family

ID=20415425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000615381A Expired - Fee Related JP4270759B2 (ja) 1999-05-03 2000-05-03 新規化合物

Country Status (23)

Country Link
US (2) US7354895B1 (ja)
EP (1) EP1180099A1 (ja)
JP (1) JP4270759B2 (ja)
KR (1) KR20020010631A (ja)
CN (1) CN1358187A (ja)
AR (1) AR028826A1 (ja)
AU (1) AU4447100A (ja)
BR (1) BR0010256A (ja)
CA (1) CA2371215A1 (ja)
CZ (1) CZ20013931A3 (ja)
EE (1) EE200100573A (ja)
HK (1) HK1042493A1 (ja)
HU (1) HUP0202379A3 (ja)
IL (1) IL145953A0 (ja)
IS (1) IS6141A (ja)
MX (1) MXPA01011043A (ja)
NO (1) NO20015374D0 (ja)
PL (1) PL356140A1 (ja)
SE (1) SE9901572D0 (ja)
SK (1) SK15662001A3 (ja)
TR (1) TR200103144T2 (ja)
WO (1) WO2000066550A1 (ja)
ZA (2) ZA200108966B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02002671A (es) 1999-09-14 2002-07-30 Meiji Seika Kaisha Derivado de acido fosfonico que tiene actividad inhibidora contra la carboxipeptidasa b.
BR0113289A (pt) * 2000-08-17 2003-06-17 Pfizer Imidazóis substituìdos como inibidores de tafia
SE0103272D0 (sv) 2001-09-28 2001-09-28 Astrazeneca Ab Chemical compounds
AP2004003084A0 (en) * 2002-01-22 2004-09-30 Pfizer 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
BR0307033A (pt) 2002-01-22 2004-12-07 Pfizer ácidos 3-(imidazolil)-2-aminopropanóicos para o uso como inibidores tafi-a para o tratamento de doenças trombóticas
US6713496B2 (en) 2002-01-22 2004-03-30 Pfizer Inc 3-(imidazolyl)-2-alkoxypropanoic acids
KR100954651B1 (ko) * 2002-03-21 2010-04-27 바이엘 쉐링 파마 악티엔게젤샤프트 혈장 카르복시펩티드분해효소 ｂ 억제제
NZ592764A (en) 2008-10-29 2012-08-31 Taisho Pharmaceutical Co Ltd Compound having tafia inhibitory activity
IL285108B1 (en) * 2019-02-08 2024-06-01 Astrazeneca Ab Arginase inhibitors and methods of using them
CN111110837B (zh) * 2020-01-06 2022-11-25 中国人民解放军陆军军医大学 一种羧肽酶抑制剂在制备预防重症致死性轮状病毒感染药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2516307A (en) * 1949-01-06 1950-07-25 Gen Mills Inc Vinyl resins plasticized with cyano esters
US4560680A (en) * 1982-03-15 1985-12-24 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
US4849414A (en) * 1986-06-11 1989-07-18 E. R. Squibb & Sons, Inc. Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors
FR2610951B1 (fr) * 1987-02-17 1989-05-05 Aerospatiale Armature tissee pour materiau composite
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
JPH07502507A (ja) * 1991-12-17 1995-03-16 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド ビスホスホネート類及び副甲状腺ホルモンを用いた骨粗鬆症の治療方法
US5550119A (en) * 1995-03-02 1996-08-27 Ciba-Geigy Corporation Phosphono substituted tetrazole derivatives as ECE inhibitors
US5672592A (en) * 1996-06-17 1997-09-30 Guilford Pharmaceuticals Inc. Certain phosphonomethyl-pentanedioic acid derivatives thereof
JP3440305B2 (ja) * 1997-04-02 2003-08-25 高砂香料工業株式会社 ７−（ｎ−置換アミノ）−２−フェニルヘプタン酸 エステル誘導体及び該誘導体の製造方法
DK0970046T3 (da) 1997-02-27 2004-04-13 Wyeth Corp N-Hydroxy-2-(alkyl-, aryl- eller heteroarylsulfanyl, -sulfinyl eller -sulfonyl)-3-substituerede alkyl- eller heteroaryl-amider som matrixmetalloproteinaseinhibitorer
AR023819A1 (es) * 1999-05-03 2002-09-04 Astrazeneca Ab FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION
SE9901573D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
MXPA02002671A (es) * 1999-09-14 2002-07-30 Meiji Seika Kaisha Derivado de acido fosfonico que tiene actividad inhibidora contra la carboxipeptidasa b.

Similar Documents

Publication Publication Date Title
BE2017C009I2 (ja)
BE2016C018I2 (ja)
BE2015C062I2 (ja)
BE2014C035I2 (ja)
BE2013C060I2 (ja)
BE2010C019I2 (ja)
BE2010C008I2 (ja)
JP2003530141A5 (ja)
JP2004505434A5 (ja)
JP2001195015A5 (ja)
BRPI0110940B8 (ja)
AR028236A3 (ja)
AU2000236813A8 (ja)
JP2001082984A5 (ja)
JP2003500786A5 (ja)
JP2002044525A5 (ja)
JP2002091569A5 (ja)
JP2002543179A5 (ja)
BRPI0113372A8 (ja)
JP2002033035A5 (ja)
JP2001249462A5 (ja)
JP2001358781A5 (ja)
JP2003500848A5 (ja)
JP2002140748A5 (ja)
CN300955183S (zh) 连接件